From a global health perspective, if you can give a vaccine at birth, a much higher percentage of the population can be covered.

We found that when most Toll-like receptors are stimulated, newborns' immune responses are very impaired. But there was one important exception.

As we better understand the molecular pathways that account for newborns' susceptibility to infections, we can leverage them to enhance their immune defenses.